%0 Journal Article
%T A Case of COVID-19 Related Myasthenic Crisis: Lessons Learned
%A Folajimi M. Otubogun
%A Adegoke M. Fatunwase
%A Olaniyi M. Fowosola
%A Khadijat M. Alli
%A Ojuolape O. Okedara
%A Bamidele S. Osalusi
%J International Journal of Clinical Medicine
%P 333-337
%@ 2158-2882
%D 2023
%I Scientific Research Publishing
%R 10.4236/ijcm.2023.148028
%X <strong>Background: </strong>COVID-19 was initially described to affect the respiratory system, it is now known to affect other systems and present in a myriad of ways. This has often proved to be a diagnostic and therapeutic challenge to clinicians and stretched healthcare resources, sometimes with poor outcomes. We report on an atypical presentation of SARS-CoV-2 infection as an acute exacerbation of myasthenia gravis in a low resource setting.<strong> Case Presentation: </strong>A middle aged male with myasthenia gravis presented with a three weeksĄŻ history of worsening generalized weakness and three daysĄŻ history of new-onset dysphagia with no history of fever and cough. After a few days of apparent improvement, the patient developed progressive respiratory distress. Further evaluation confirmed bilateral pneumonia and COVID-19. <strong>Conclusion: </strong>There is a need for clinicians and health service providers to have a low threshold for suspicion and testing for COVID-19 in patients with pre-existing medical conditions and immunomodulatory therapy such as Myasthenia gravis.
%K Myasthenia Gravis
%K COVID-19
%K SARS-COV-2
%K Low Resource Settings
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=126807